Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.67B |
| 2 |
Snowflake
SNOW
|
+$1.03B |
| 3 |
Shopify
SHOP
|
+$940M |
| 4 |
TJX Companies
TJX
|
+$933M |
| 5 |
TSMC
TSM
|
+$779M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$3.39B |
| 2 |
Alibaba
BABA
|
+$1.33B |
| 3 |
AstraZeneca
AZN
|
+$1.12B |
| 4 |
Mastercard
MA
|
+$968M |
| 5 |
Goldman Sachs
GS
|
+$911M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Consumer Discretionary | 23.94% |
| 3 | Communication Services | 14.59% |
| 4 | Financials | 8.49% |
| 5 | Healthcare | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILK
151
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $70.8M | 0.05% |
1,124,280
-130,483
| -10% | -$8.1M |
|
|
SUM
152
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $70.6M | 0.05% |
3,574,494
-163,065
| -4% | -$3.03M |
|
153
Fate Therapeutics
FATE
$291M
| $70.5M | 0.05% |
775,357
-240,712
| -24% | -$14.9M |
|
154
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $70.4M | 0.05% |
1,092,996
-177,163
| -14% | -$9.13M |
|
155
FedEx
FDX
$73.2B
| $69.3M | 0.05% |
267,007
+94,727
| +55% | +$26.2M |
|
156
Marvell Technology
MRVL
$174B
| $69.2M | 0.05% |
1,456,332
-642,574
| -31% | -$27.8M |
|
157
Jack in the Box
JACK
$324M
| $69.2M | 0.05% |
745,582
+41,110
| +6% | +$3.6M |
|
158
Align Technology
ALGN
$12.4B
| $68.7M | 0.05% |
128,639
-17,110
| -12% | -$7.69M |
|
|
MRSH
159
Marsh
MRSH
$92B
| $67.6M | 0.05% |
577,475
+24,947
| +5% | +$2.83M |
|
160
SLM Corp
SLM
$5.09B
| $67.5M | 0.05% |
5,451,498
-38,359
| -0.7% | -$403K |
|
161
Azenta
AZTA
$1.38B
| $67.1M | 0.05% |
988,579
-144,231
| -13% | -$8.99M |
|
162
Freshpet
FRPT
$2.93B
| $66.9M | 0.05% |
470,935
+140,846
| +43% | +$18.2M |
|
|
GLDD
163
DELISTED
Great Lakes Dredge & Dock
GLDD
| $66.7M | 0.05% |
5,063,558
-41,129
| -0.8% | -$460K |
|
164
Boston Scientific
BSX
$72B
| $66.4M | 0.05% |
1,848,151
-5,483,346
| -75% | -$198M |
|
165
CoStar Group
CSGP
$12.2B
| $66.3M | 0.05% |
717,510
+45,630
| +7% | +$4M |
|
166
Bankunited
BKU
$3.4B
| $63.8M | 0.05% |
1,833,375
-239,262
| -12% | -$6.83M |
|
167
Varonis Systems
VRNS
$4.73B
| $63.7M | 0.05% |
1,168,734
-349,941
| -23% | -$15.2M |
|
|
ACC
168
DELISTED
American Campus Communities, Inc.
ACC
| $63.6M | 0.05% |
1,486,936
+62,249
| +4% | +$2.48M |
|
169
10x Genomics
TXG
$5.97B
| $63M | 0.04% |
444,609
+93,554
| +27% | +$13.6M |
|
170
Abbott
ABT
$185B
| $62.6M | 0.04% |
571,425
-164,240
| -22% | -$17.9M |
|
|
RVNC
171
DELISTED
Revance Therapeutics, Inc.
RVNC
| $62.4M | 0.04% |
2,201,508
-84,534
| -4% | -$2.19M |
|
|
HZNP
172
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $62.1M | 0.04% |
848,747
+22,794
| +3% | +$1.69M |
|
173
Insulet
PODD
$11.8B
| $61.7M | 0.04% |
241,395
-23,613
| -9% | -$5.86M |
|
174
Pinterest
PINS
$13.5B
| $61.2M | 0.04% |
928,304
-744,494
| -45% | -$44.7M |
|
175
Monolithic Power Systems
MPWR
$66B
| $60.9M | 0.04% |
166,187
-51,299
| -24% | -$16.4M |
|
Similar funds
Jennison Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Jennison Associates held 734 positions worth $140B, up 13% from $124B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q4 2020 filing shows 114 new, 205 increased, 311 reduced and 95 closed positions. Its largest new stake was Farfetch Limited Class A Ordinary Shares: 13,694,960 shares worth $874M. The largest sale was Tesla, an estimated $3.39B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2020 buy was Farfetch Limited Class A Ordinary Shares: 13,694,960 shares worth $874M.
- Jennison Associates added most to Block Inc in Q4 2020, an estimated $1.67B increase.
- Jennison Associates's biggest Q4 2020 reduction was Tesla, cutting an estimated $3.39B.
- Jennison Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $181M.
- Jennison Associates's ten largest holdings make up 40% of its $140B portfolio in Q4 2020.
- Jennison Associates opened 114 new positions and closed 95 in Q4 2020.
- Jennison Associates's portfolio value rose 13% quarter-over-quarter to $140B.
Based on Jennison Associates's 13F filing for Q4 2020, filed 5 Feb 2021.